Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.44 |
| ▸ | GABRD | O14764 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.44 |
| ▸ | GABRE | P78334 | 1/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.44 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.44 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.44 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15203462 | 0.98 | KDM4E (0.66) | KDM4ECYP3A4ACHEGABRPGABRD | |
| SCHEMBL26963250 | 0.84 | KDM4E (0.50) | KDM4ECYP3A4KMT2AMEN1TDP1 | |
| SCHEMBL15214028 | 0.83 | KDM4E (0.47) | KDM4ECYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL17779280 | 0.83 | KDM4E (0.47) | KDM4ECYP3A4ACHETDP1ALDH1A1 | |
| SCHEMBL5424439 | 0.81 | KDM4E (0.70) | KDM4ECYP3A4GABRPGABRDGABRA1 | |
| SCHEMBL108376 | 0.81 | KDM4E (1.00) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL29502911 | 0.81 | KDM4E (1.00) | KDM4EGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL1553215 | 0.81 | KDM4E (0.70) | KDM4ECYP3A4GABRPGABRDGABRA1 | |
| Hydrochloric Acid SCHEMBL5430842 | 0.79 | KDM4E (0.68) | KDM4ECYP3A4GABRPGABRDGABRA1 | |
| SCHEMBL27462101 | 0.79 | KDM4E (0.68) | KDM4EGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION (KR) | 2025-05-15 | — | — | US | claimed |
| WO-2023140435-A1 | METHOD FOR SYNTHESIZING AVENANTHRAMIDES C | 동아대학교 산학협력단 | 2023-07-27 | — | — | WO | claimed |
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION (KR) | 2025-05-15 | — | — | US | disclosed |
| WO-2023140435-A1 | METHOD FOR SYNTHESIZING AVENANTHRAMIDES C | 동아대학교 산학협력단 | 2023-07-27 | — | — | WO | disclosed |
| US-20030073862-A1 | Compounds | BIOVITRUM AB (SE) | 2003-04-17 | — | — | US | disclosed |
| WO-2003004458-A1 | NEW COMPOUNDS | BIOVITRUM AB (SE) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154095-A1 | SYNTHESIS METHOD OF AVENANTHRAMIDE C | OAT, MCCC2, OTC | KDM4E 1289/4885CYP3A4 1116/4885ACHE 1256/4885 |
| US-20030073862-A1 | Compounds | PPARG, PPARA, PPARD | KDM4E 2125/4885CYP3A4 508/4885ACHE 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.